Kindai University · Kindai University Hospital

Research keywordsthoracic oncology・NSCLC mutations・thymic carcinoma・MAC lung disease・MET resistance

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Eribulin-induced Interstitial Pneumonia: A Case Series and Retrospective Cohort Study.
• Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study).
• Primary Synovial Sarcoma of the Mediastinum with Long-term Follow-up.
• Is EGFR back? ADCs revive targeted therapy in nasopharyngeal carcinoma.

• KRAS阻害薬の耐性機序の解明と克服
• 免疫チェックポイント阻害薬による免疫関連有害事象の発症及び重症化のリスク因子解析
• HER2遺伝子変異陽性固形癌に対する抗体薬物複合体/分子標的薬併用療法の作用 機序と耐性機序の解明
• がん幹細胞系マーカー及びTumor mutation burdenと術後再発の関連性の解明

• Official profile